Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:oxytocin
|
| gptkbp:administeredBy |
intravenous infusion
intramuscular injection |
| gptkbp:approvedBy |
1955
|
| gptkbp:ATCCode |
gptkb:H01BB02
|
| gptkbp:CASNumber |
50-56-6
|
| gptkbp:chemicalFormula |
C43H66N12O12S2
|
| gptkbp:contraindication |
gptkb:cephalopelvic_disproportion
fetal distress without delivery obstructive birth canal unengaged fetal head |
| https://www.w3.org/2000/01/rdf-schema#label |
Pitocin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Par_Pharmaceutical
|
| gptkbp:marketedIn |
gptkb:Canada
gptkb:United_Kingdom gptkb:United_States |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:relatedTo |
gptkb:Syntocinon
synthetic oxytocin |
| gptkbp:routeOfAdministration |
IV
IM |
| gptkbp:sideEffect |
gptkb:fetal_distress
gptkb:uterine_hyperstimulation water intoxication |
| gptkbp:UNII |
1J444QC288
|
| gptkbp:usedFor |
augmentation of labor
induction of labor postpartum hemorrhage control |
| gptkbp:bfsParent |
gptkb:Oxytocin
|
| gptkbp:bfsLayer |
7
|